SW
NVO

Solidarity Wealth’s Novo Nordisk NVO Stock Holding History

Solidarity Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-76,918
Closed -$4.29M – 87
2025
Q3 		$4.29M Buy
76,918
+5,483
+8% +$321K 0.92% 30
2025
Q2 		$4.93M Buy
71,435
+59,933
+521% +$4.08M 1.15% 26
2025
Q1 		$802K Buy
+11,502
New +$950K 0.2% 56

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Solidarity Wealth's NVO Position: Q4 2025 in Review

Solidarity Wealth sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 76,918 shares — an estimated $4.29M sold.

Solidarity Wealth first reported a position in NVO in Q1 2025 and held it in 3 quarters. The position peaked at $4.93M in Q2 2025. 1,414 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Solidarity Wealth reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Solidarity Wealth sold 76,918 Novo Nordisk shares in Q4 2025, an estimated $4.29M.
  • Solidarity Wealth first reported a position in Novo Nordisk in Q1 2025 and held it in 3 quarters.
  • Solidarity Wealth's Novo Nordisk position peaked at $4.93M in Q2 2025.
  • 1,414 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Solidarity Wealth's 13F filing for Q4 2025, filed 29 Jan 2026.